REQUEST A DEMO
Total
USD $0.00
Search more companies

Trpharm Ilac Sanayi Ticaret A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Trpharm Ilac Sanayi Ticaret Anonim Sirketi Profile Updated: July 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

trpharm is a pharmaceutical industry company. The company focuses on developing solutions for various health needs, including rare diseases. trpharm also offers services for drug discovery, development, production, and regulatory work to accelerate the drug development process. The company is expanding its export activities internationally.

Headquarters
Kanyon Of.blg. K.14 N:185 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Trpharm Ilac Sanayi Ticaret A.S. report to view the information.

Website: http://www.trpharm.com

Basic Information
Total Employees:
Purchase the Trpharm Ilac Sanayi Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Trpharm Ilac Sanayi Ticaret A.S. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Trpharm Ilac Sanayi Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
410.56%
Total operating revenue
410.56%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
329.23%
Total equity
48.56%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
229.97%
Quick Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?